Wake up man. LBT has products that still lives in the past. Not...

Wake up man. LBT has products that still lives in the past. Not many labs are going to invest $300K and $100K (or $50K, I forget) annual license fee for a product that adds little benefit to current workflow. Don't be upset that I have different opinion to you, just do your research on current trend in microbiology. I'll give you one insight.

Let's look at one example I posted above. Biofire has FDA Approved (in 2013) product called, Filmarray BCID (blood culture identification). Biofire Filmarray already has installed base of 21,400 world-wide (primarily because of their respiratory viruses panel) . If you are a lab operator, would you try to utilise Filmarray that they already have? or Buy APAS Independence that has upfront cost of $300K?

This is just one example, there are plenty of products out there that completely bypasses culturing of positive blood culture samples. I can't understand why anyone would invest in the technology of the past.

Have a good day